Advanced search
Publication Cover
Statistics in Biopharmaceutical Research Volume 15, 2023 - Issue 2
Submit an article Journal homepage
709
Views
0
CrossRef citations to date
0
Altmetric
Announcement

Statistics in Biopharmaceutical Research Best Papers Award 2023

Toshimitsu Hamasakia The George Washington University Biostatistics Center, Rockville, MD;b Department of Biostatistics and Bioinformatics, Milken Institute School of Public Health, The George Washington University, Washington, DCCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-4928-1160View further author information
ORCID Icon &
Freda Coonerc Statistics, Eli Lilly and Company, Indianapolis, INView further author information
Pages 235-236 | Published online: 22 May 2023

References

  • Bretz, F., Maurer, W., Brannath, W., and Posch, M. (2009), “A Graphical Approach to Sequentially Rejective Multiple Test Procedures,” Statistics in Medicine, 28, 586–604. DOI: 10.1002/sim.3495.
  • Guizzaro, L., Pétavy, F., Ristl, R., and Gallo, C. (2021), “The Use of a 1Variable Representing Compliance Improves Accuracy of Estimation of the Effect of Treatment Allocation Regardless of Discontinuation in Trials with Incomplete Follow-up,” Statistics in Biopharmaceutical Research, 13, 119–127. DOI: 10.1080/19466315.2020.1736141.
  • Hua, E., Janocha, R., Severin, T., Wei, J., and Vandemeulebroecke, M. (2022), “A Phase 3 Trial Analysis Proposal for Mitigating the Impact of the COVID-19 Pandemic,” Statistics in Biopharmaceutical Research, 14, 80–86. DOI: 10.1080/19466315.2021.1905056.
  • ICH (2019), “Addendum on Estimands and Sensitivity Analysis in Clinical Trials to the Guideline on Statistical Principles for Clinical Trials E9(R1),” available at https://database.ich.org/sites/default/files/E9-R1_Step4_Guideline_2019_1203.pdf.
  • Lui, G. F., Liu, J., Chen, F., Gutman, R., and Lu, K. (2022), “Bayesian Approaches for Handling Hypothetical Estimands in Longitudinal Clinical Trials with Gaussian Outcomes,” Statistics in Biopharmaceutical Research, 14, 626–635. DOI: 10.1080/19466315.2021.1924256.
  • Maurer, W., and Bretz, F. (2013), “Multiple Testing in Group Sequential Trials Using Graphical Approaches,” Statistics in Biopharmaceutical Research, 5, 311–320. DOI: 10.1080/19466315.2013.807748.
  • Xu, Y., Wu, M., He, W., Liao, Q., and Mai, Y. (2022), “Teasing Out the Overall Survival Benefit With Adjustment for Treatment Switching to Multiple Treatments,” Statistics in Biopharmaceutical Research, 14, 592–601. DOI: 10.1080/19466315.2021.1914716.
  • Zhan, T., Hartford, A., Kang, J., and Offen, W. (2022), “Optimizing Graphical Procedures for Multiplicity Control in a Confirmatory Clinical Trial via Deep Learning,” Statistics in Biopharmaceutical Research, 14, 92–102. DOI: 10.1080/19466315.2020.1799855.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.